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ABSTRACT 
Background: The objective of this study was to develop and validate a short form of 
the Patient Health Questionnaire-9 (PHQ-9), a self-report questionnaire for assessing 
depressive symptomatology, using objective criteria.  
Methods: Responses on the PHQ-9 were obtained from 7,850 English-speaking 
participants enrolled in 20 primary diagnostic test accuracy studies. PHQ 
unidimensionality was verified using confirmatory factor analysis, and an item response 
theory model was fit. Optimal test assembly (OTA) methods identified a maximally 
precise short form for each possible length between 1 and 8 items, including and 
excluding the 9th item. The final short form was selected based on pre-specified validity, 
reliability, and diagnostic accuracy criteria.  
Results: A 4-item short form of the PHQ (PHQ-Dep-4) was selected. The PHQ-Dep-4 
had a Cronbach’s alpha of 0.805. Sensitivity and specificity of the PHQ-Dep-4 were 
0.788 and 0.837, respectively, and were statistically equivalent to the PHQ-9 (sensitivity 
= 0.761, specificity = 0.866). The correlation of total scores with the full PHQ-9 was high 
(r = 0.919). 
Conclusion: The PHQ-Dep-4 is a valid short form with minimal loss of information of 
scores when compared to the full-length PHQ-9. Although OTA methods have been 
used to shorten patient-reported outcome measures based on objective, pre-specified 
criteria, further studies are required to validate this general procedure for broader use in 
health research. Furthermore, due to unexamined heterogeneity, there is a need to 
Patient Health Questionnaire–Depression-4 
 9 
replicate the results of this study in different patient populations. 
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Introduction  
In mental health research and clinical practice, self-report symptom measures are used to 
assess patient symptoms and identify patients with undetected mental disorders. Completing 
these measures is demanding, especially when people are asked to respond to multiple measures 
that each contain multiple items (Coste et al., 1997; Goetz, Lemetayer, & Rat, 2013; Kruyen, 
Emons, & Sijtsma, 2013; Stanton, Sinar, Balzer., & Smith, 2002). Therefore, researchers attempt 
to create shortened versions with scores that perform comparably well with original full-length 
versions (Coste et al., 1997; Goetz et al., 2013; Kruyen et al., 2013; Stanton, Sinar, Balzer, & 
Smith, 2002). (Goetz et al., 2013) 
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item, self-report questionnaire that 
measures depressive symptomatology (Kroenke et al., 2009; Kroenke & Spitzer, 2002; Kroenke, 
Spitzer, & Williams, 2001). A recent meta-analysis of the PHQ-9 found that at the standard cutoff 
of 10, based on 34 studies, the sensitivity and specificity were 0.78 and 0.87, respectively 
(Moriarty, Gilbody, McMillan, & Manea, 2015).  
The PHQ-8 is similar to the PHQ-9 and is increasingly used because it eliminates one 
item that asks about patients’ thoughts of either self-harm or being “better off dead” (Kroenke & 
Spitzer, 2002), but it identifies large numbers of patients not at risk of suicide (Dube, Kroenke, 
Bair, Theobald, & Williams, 2010; Razykov, Hudson, Baron, & Thombs, 2013). Many studies 
have reported that the PHQ-8 performs nearly identically to the PHQ-9 (Corson, Gerrity, & 
Dobscha, 2004; Kroenke & Spitzer, 2002; Leadbeater, Carruthers, Green, Rosser, & Field, 2011; 
Razykov et al., 2013).  
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The PHQ-2 is another short-form, designed to include the two core items in a Diagnostic 
and Statistical Manual of Mental Disorders (DSM) Major Depressive Disorder (MDD) 
diagnosis: depressed mood and anhedonia (Kroenke, Spitzer, & Williams, 2003). A recent meta-
analysis of the PHQ-2 found that at a cutoff of 2, based on 17 studies, the sensitivity and 
specificity were 0.91 and 0.70, respectively, while at a cutoff of 3, based on 19 studies, the 
sensitivity and specificity were 0.76 and 0.87, respectively (Manea et al., 2016).  
Conventionally, short forms of patient-report measures are created through an expert-
based analysis of item content, as with the PHQ-2, or by removing items with minimal factor 
loadings (Goetz et al., 2013). These methods are not typically applied in a systematic way, and 
multiple shortened versions of the same measure may exist (Coste et al., 1997; Goetz et al., 
2013; Kruyen et al., 2013; Smith, McCarthy, & Anderson, 2000; Stanton, Sinar, Balzer, & Smith, 
2002). Methods such as item response theory (IRT; van der Linden & Hambleton, 1997) have 
been used to evaluate and identify problematic items, but have not incorporated objective and 
reproducible criteria for item selection. 
Optimal test assembly (OTA) is a mixed-integer programming procedures that uses an 
estimated IRT model to select the subset of items that best satisfies pre-specified constraints (van 
der Linden, 2006). Although more commonly used in the development of high-stakes educational 
tests (Holling, Kuhn, & Kiefer, 2013), a recent study demonstrated that OTA can be used to 
develop shortened versions of patient-reported outcome measures (A. W. Levis et al., 2016). This 
procedure was also shown to be replicable, reproducible, and produce shortened forms of 
minimal length as compared with leading alternative methods (Harel & Baron, 2018).  
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The objective of the present study was to apply OTA to develop a shortened version of 
the PHQ-9. We (1) used confirmatory factor analysis to verify the unidimensionality of the 
underlying construct; (2) applied OTA methods to obtain candidate forms of each possible 
length; and (3) selected the shortest possible form that showed similar performance to the full 
form in terms of pre-specified validity, reliability, and diagnostic accuracy criteria, compared to 
the PHQ-9 as the full-form standard.  
MATERIALS AND METHODS 
This study used a subset of data accrued for an individual participant data meta-analysis 
(IPDMA) on the diagnostic accuracy of the PHQ-9 depression screening tool to detect major 
depression (in progress). The IPDMA was registered in PROSPERO (CRD42014010673), and a 
protocol was published (Thombs et al., 2014).   
Search Strategy 
A medical librarian searched Medline, Medline In-Process & Other Non-Indexed 
Citations via Ovid, PsycINFO, and Web of Science (January 2000 - December 2014) on 
February 7, 2015, using a peer-reviewed search strategy (Supplementary Methods 1). We also 
reviewed reference lists of relevant reviews and queried contributing authors about non-
published studies. Search results were uploaded into RefWorks (RefWorks-COS, Bethesda, MD, 
USA). After de-duplication, unique citations were uploaded into DistillerSR (Evidence Partners, 
Ottawa, Canada), for storing and tracking search results. 
Identification of Eligible Studies for Full IPDMA 
Datasets from articles in any language were eligible for inclusion if they included 
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diagnostic classifications for current MDD or Major Depressive Episode (MDE) based on a 
validated semi-structured or fully structured interview conducted within two weeks of PHQ-9 
administration, among participants ≥18 years and not recruited from youth or psychiatric 
settings. Datasets where not all participants were eligible were included if primary data allowed 
selection of eligible participants. For defining major depression, we considered MDD or MDE 
based on the DSM or MDE based on the International Classification of Diseases (ICD). If more 
than one was reported, we prioritized DSM over ICD and DSM MDE over DSM MDD. Across 
all studies, there were 23 discordant diagnoses depending on classification prioritization (0.1% of 
participants). 
Two investigators independently reviewed titles and abstracts for eligibility. If either 
deemed a study potentially eligible, full-text review was completed by two investigators, 
independently, with disagreements resolved by consensus,  consulting a third investigator when 
necessary. Translators were consulted to evaluate titles, abstracts and full-text articles. 
Data Contribution and Synthesis 
Authors of eligible datasets were invited to contribute de-identified primary data. We 
compared published participant characteristics and diagnostic accuracy results with results from 
raw datasets and resolved any discrepancies in consultation with the original investigators.  
Data Selection for Present Study 
 We restricted our dataset to participants who completed the PHQ-9 in English, due to the 
potential for heterogeneity across studies conducted in different languages. We excluded studies 
that classified major depression using the Mini International Neuropsychiatric Interview (MINI), 
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because it is structurally different from other fully structured interviews and classifies 
approximately twice as many participants as cases compared to the most commonly used fully-
structured interview, the Composite International Diagnostic Interview (CIDI) (B. Levis et al., 
Br. J. Psychiatry 2018).   
Measure 
Scores on each PHQ-9 item reflect frequency of symptoms in the last two weeks and 
range from 0 (“not at all”) to 3 (“nearly every day”). Higher scores indicate greater depressive 
symptomatology. Total scores range from 0 to 27 (Kroenke et al., 2001).  
Statistical Analyses 
Verification of Unidimensionality of the PHQ-9 
 Robust weighted least squares estimation in Mplus was used to fit a single-factor 
confirmatory factor analysis model of PHQ-9 items (Muthén & Muthén, 2012). The model was 
first fit without allowing for any residual correlations among the items. Then modification 
indices were used to identify item pairs that would improve model fit if their residuals were 
allowed to correlate, if there was theoretical justification (McDonald & Ho, 2002). Model fit was 
evaluated concurrently, using: the 𝜒2statistic, Comparative Fit Index (CFI), Tucker-Lewis Index 
(TLI), and Root Mean Square Error of Approximation (RMSEA) (Feinian Chen, Curran, Bollen, 
Kirby, & Paxton, 2008). Priority was given to CFI, TLI, and RMSEA, because the 𝜒2test may 
reject well-fitting models when sample size is large (Reise, Widaman, & Pugh, 1993). Model fit 
was considered adequate if CFI and TLI ≥ 0.95 and RMSEA ≤ 0.08 (Hu & Bentler, 1999).  
Item Response Theory Model and Optimal Test Assembly 
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 A generalized partial credit model (GPCM) was fit to PHQ-9 (Muraki, 1992). The GPCM 
is an IRT model that relates a latent trait, representing severity of depressive symptomatology, to 
the distribution of observed item-level responses. The GPCM estimates two types of item-
specific parameters: a discrimination parameter and threshold parameters. From these item-level 
parameter estimates, item information functions for each item were calculated from the GPCM, 
as well as a test information function (TIF), obtained by summing item information functions. 
Because the TIF is inversely related to the standard error of measurement of the latent trait, high 
amounts of information represent greater precision for measuring depressive symptomatology.  
 Next, we used OTA, a mixed-integer programming technique to systematically search for 
the short form that maximized the TIF, subject to the constraint of fixing the number of items 
included in each short form, optimizing the precision of the short form in estimating participants’ 
level of depressive symptomatology (Boekkooi-Timminga, 1989; van der Linden, 2006). The 
shape of the TIF was anchored at five points (van der Linden, 2006). Thus, for each short form of 
lengths 1 to 8 items, OTA selected items from the full set of the nine PHQ-9 items that 
maximized test information. Due to concerns about the use of the ninth item of the PHQ (Corson 
et al., 2004; Dube et al., 2010; Lee, Schulberg, Raue, & Kroenke, 2007; Razykov et al., 2013; 
Rief, Nanke, Klaiberg, & Braehler, 2004), the same procedure was used to generate 8 additional 
short forms that were forced to exclude the ninth item. In total, the OTA procedure yielded 16 
candidate short forms.  
For each of the 16 candidate short forms and the full-length form, two scoring procedures 
were used to obtain estimates of each participant’s level of depressive symptomatology. First, the 
Patient Health Questionnaire–Depression-4 
 16 
summed scores across all items included in the short form were calculated. Second, factor scores 
were estimated for each participant. Although summed scores are typically relied upon for 
clinical use, the factor scores were considered to provide a better estimate of the latent trait due 
to well-known limitations of the summed score under the GPCM (Harel, 2014; van der Ark, 
2005).  
Selection of Final Short Form 
The selection of the final short form was based on the following five criteria: reliability, 
concurrent validity of summed scores, concurrent validity of factor scores, and non-inferior 
sensitivity and specificity, since the elimination of items necessarily reduces information 
compared to a full-length form. 
Reliability of each candidate short form was assessed with Cronbach’s alpha (Cronbach, 
1951). The final selected form was required a priori to have a Cronbach’s alpha coefficient ≥ 
0.80. Concurrent validity of the summed scores and factor scores was measured with the 
Pearson’s correlation coefficient between the full-length form and candidate short form scores, 
and were required a priori to be ≥ 0.90. 
Diagnostic accuracy of each candidate short form was assessed through a three-step 
process. First, the sensitivity and specificity of each candidate short form for each of its possible 
cutoff summed score values was estimated with a bivariate random-effects model. Second, for 
each candidate short form, an optimal cutoff score was selected using Youden’s J statistic 
(Youden, 1950). For the full-length form, the conventionally used cutoff score of 10 was selected 
(Gilbody, Richards, Brealey, & Hewitt, 2007; Kroenke et al., 2001; Kroenke & Spitzer, 2002; 
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Spitzer et al., 2000; Wittkampf, Naeije, Schene, Huyser, & van Weert, 2007). Third, two non-
inferiority tests were conducted for each of the 16 candidate forms to compare sensitivity and 
specificity, separately, to the full-length form. Non-inferiority tests assess whether the sensitivity 
or specificity of the short form is not lower than that of the full-length form, up to a pre-specified 
clinically-significant tolerance (Counsell & Cribbie, 2015), such as 𝛿 = 0.05. To conduct the 
non-inferiority test, the sampling distribution of the test statistic was generated through the 
bootstrap method (Liu, Ma, Wu, & Tai, 2006). Bootstrapping resamples the original dataset, with 
replacement, to generate new, artificial, datasets (Efron & Tibshirani, 1994). For each non-
inferiority test, 2000 bootstrap iterations were conducted, controlling in each for the number of 
respondents with and without major depression. For each bootstrap iteration, the bivariate 
random-effects model was fit to each of the 16 candidate short forms and the full-length form, 
and the sensitivities and specificities were computed based on their cutoff scores. To account for 
the multiple testing in the 32 total non-inferiority tests, the Benjamini-Hochberg adjusted p-value 
was used to determine the significance of the test at the 0.05 signficance level (Benjamini & 
Hochberg, 1995).  
The factor analysis was conducted using Mplus 7 (Muthén & Muthén, 2012). All other 
analyses were conducted using R version 3.3.3 (R Core Team, 2017). The GPCM was fit using 
the ltm package (Rizopoulos, 2006). The OTA analysis was conducted using the lpSolveAPI 
package (Diao & van der Linden, 2011). The bivariate random-effects model was fit using the 
lme4 package (Bates, Mächler, Bolker, & Walker, 2015).  
RESULTS 
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Search Results and Inclusion of Primary Data 
Of 5,248 unique titles and abstracts identified from the database search, 5,039 were 
excluded after title and abstract review and 113 after full-text review, leaving 96 eligible articles 
with data from 69 unique participant samples, of which 55 (80%) contributed datasets 
(Supplementary Figure 1). Authors of included studies contributed data from three unpublished 
studies, for a total of 58 datasets. Of these, we excluded 32 studies that administered the PHQ-9 
in a language other than English and 6 more that used the MINI. In total, 7,850 participants (863 
major depression cases) from 20 primary studies were included. These studies were conducted in 
the USA, New Zealand, Australia, Canada, the UK, and Cameroon. The mean age of the sample 
was 33.9 years, and 55.3% of participants were women. See Table 1 for descriptive sample 
statistics, and Supplementary Table 1 for characteristics of each included study. 
Unidimensionality of PHQ-9 
A single factor model was fit to the PHQ-9 items with no specification of residual 
correlations (𝜒2[𝑑𝑓 = 36] = 1578.7, 𝑝 < 0.0001, 𝑇𝐿𝐼 = 0.966, 𝐶𝐹𝐼 = 0.974,𝑅𝑀𝑆𝐸𝐴 =
0.086). Modification indices indicated improvement of model fit if residuals of items that 
measure physical symptoms (items 3, 4, and 5) were correlated. The model was refitted with 
specification of three correlated residuals, and fit improved (𝜒2[𝑑𝑓 = 39] = 750.2, 𝑝 <
0.0001, 𝑇𝐿𝐼 = 0.982, 𝐶𝐹𝐼 = 0.988,𝑅𝑀𝑆𝐸𝐴 = 0.062). Factor loadings for items were all 
moderately high, with a median of 0.763 and a range of 0.665 to 0.877. 
Item Response Theory Model and Optimal Test Assembly 
Table 2 presents discrimination parameters for each item based on the GPCM. The item 
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with the greatest discrimination parameter was item 2. Other items with high values were items 1 
and 6. Figure 1 shows the information function of each of the 9 items, as well as the total TIF. 
 Table 3 shows the items that were included in each of the 16 candidate short forms from 
the OTA analysis. For the candidate forms generated both with the inclusion of item 9 and 
without, items 3, 4, and 5 were only selected in the longest short forms, and quickly dropped 
thereafter. Items 1, 2, and 6 were included in all forms of at least 4 items. For the short forms 
generated from the full set of nine items, item 9 was included in all candidate short forms.  
Selection of final short form 
Table 4 presents Cronbach’s alpha values and concurrent validity correlations for the 16 
candidate short forms. Table 5 presents results of the non-inferiority tests for both sensitivity and 
specificity. There were four short forms that satisfied our pre-specified criteria in terms of 
reliability, concurrent validity, and diagnostic accuracy. The four such forms were: 6-item and 7-
item short forms that included item 9 and 4-item and 5-item short forms that excluded item 9.  
The 4-item short form was the shortest form that fulfilled all criteria. The form includes: 
item 1 (“Little interest or pleasure in doing things”), item 2 (“Feeling down, depressed, or 
hopeless”), item 6 (“Feeling bad about yourself – or that you are a failure or have let yourself or 
your family down”), and item 8 (“Moving or speaking so slowly that other people could have 
noticed? Or the opposite – being so fidgety or restless that you have been moving around a lot 
more than usual”). The PHQ-Dep-4 maintained high reliability with a Cronbach’s alpha of 0.805 
(95% CI, 0.795, 0.814) compared to 0.866 for the full-length form. Correlations of the summed 
and factor scores between the PHQ-Dep-4 and PHQ-9 were 0.919 (95% CI, 0.916, 0.923) and 
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0.910 (95% CI, 0.907, 0.914), respectively. The sensitivity and specificity of the PHQ-Dep-4 at 
its optimal cutoff of 4 were 0.788 (95% CI, 0.725, 0.840) and 0.837 (95% CI, 0.809, 0.861), 
respectively. Both sensitivity and specificity were non-inferior to the sensitivity (0.761; 95% CI, 
0.679, 0.787) and specificity (0.866; 95% CI, 0.836, 0.892) of the full-length form. 
DISCUSSION 
This study illustrated how OTA methods can be used to effectively shorten self-report 
symptom measures while maintaining comparable diagnostic accuracy. OTA methods were 
applied to shorten the 9-item PHQ-9 to a 4-item version (PHQ-Dep-4). In addition to 
maintaining similar sensitivity and specificity, the short form had minimal loss of information 
and maintained reliability and validity that were comparable to the full-length form based on pre-
specified criteria. Cronbach’s alpha of the PHQ-Dep-4 was 0.805, compared to 0.866 for the full 
form. Correlations of the summed score and factor score of the PHQ-Dep-4 and PHQ-9 were 
0.919 and 0.910, respectively. Per pre-specified criteria, the sensitivity and specificity of the 
PHQ-Dep-4 (0.788 and 0.837, respectively) were within 5% of those of the PHQ-9 (0.761 and 
0.866, respectively).  
The 4 items included in the PHQ-Dep-4 included items 1, 2, 6 and 8 from the original 
PHQ-9. These items included the 2 core depression items (depressed mood and loss of interest) 
that make up the commonly used PHQ-2. According to diagnostic criteria for major depression, 
at least one of these symptoms must be present for a diagnosis. The other 2 items in the PHQ-
Dep-4 included an affective/cognitive item (feelings of failure) and a somatic item (physical 
movement). Thus, the PHQ-Dep-4 includes items that qualitatively represent the depressive 
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symptomatology construct well. We note that the PHQ-Dep-4 includes 1 somatic symptom, 
whereas the full PHQ-9 includes 4 symptoms. One study found that somatic symptoms may 
increase scores on the PHQ-9 among somatically ill patients due to factors related to somatic 
disease, but not depression, among scleroderma patients, but the association was minimal 
(Leavens, Patten, Hudson, Baron, & Thombs, 2012). Another study, of multiple sclerosis 
patients, did not find that somatic symptoms influenced scores substantively (Sjonnesen et al., 
2012).  
Both the actual PHQ-2 and the PHQ-8 were selected in the set of 16 candidate short 
forms. Neither of these, however, were selected by the OTA procedure as optimal. The PHQ-
Dep-4 has lower sensitivity than the PHQ-2 (0.788 rather than 0.880), but higher specificity 
(0.837 rather than 0.725). The PHQ-Dep-4, therefore, may represent a middle ground between 
shortening the full-length scale, while still retaining desirable measurement and diagnostic 
properties. The PHQ-Dep-4 may be a useful option in some contexts because it is shorter than 
the PHQ-9 and PHQ-8, but generates a wider score distribution than the PHQ-2. 
There are several limitations for this study that must be considered. First, for the 
collection of data for the full IPDMA, it was not possible to obtain primary data from 14 of the 
69 eligible datasets. Second, the full IPDMA excluded studies where the PHQ-9 was 
administered exclusively to patients with known psychiatric conditions. Therefore, the 
generalizability of the results should be confirmed when monitoring treatment response. Third, 
the present study only included participants for whom the PHQ-9 was administered in English. 
Fourth, a previous study showed that semi-structured and fully structured interviews have 
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different characteristics as reference standards (B. Levis et al., Br. J. Psychiatry 2018). We 
excluded studies that used the MINI, given its high rate of diagnosis relative to other diagnostic 
interviews (B. Levis et al., Br. J. Psychiatry 2018). We included studies that used both semi-
structured and fully structured interviews as reference standards, and future work should verify 
that our results apply in both cases. While our dataset included a specific sample of patients, we 
note that measurement invariance or differential item functioning requirements have been 
examined in previous studies of the PHQ-9 used as a continuous measure across variables like 
language (Arthurs, Steele, Hudson, Baron, & Thombs, 2012; Merz, Malcarne, Roesch, Riley, & 
Sadler, 2013), culture (Baas et al., 2011; Hirsch, Donner-Banzhoff, & Bachmann, 2013; Huang, 
Chung, Kroenke, Delucchi, & Spitzer, 2006), and medical diagnosis (Chung et al., 2015; Cook et 
al., 2011; Leavens et al., 2012). These studies provide some degree of confidence that the 
structure of the PHQ-9 is similar across groups. Lastly, there is a need to replicate our results in 
different patient populations due to unexamined heterogeneity across the studies included in this 
analysis. 
With regards to the OTA procedure, two limitations must be considered. First, the 
selection of a short version was sensitive to the choice of criteria for the selection of the final 
form, and should be carefully considered in future analyses Additionally, the OTA approach is 
exploratory and data-driven, and the results of this study should be replicated. 
CONCLUSION 
The study illustrates how patient self-report symptom measures can be developed and 
validated using the OTA method, which uses pre-specified objective criteria to determine the 
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length and specific items that should be included in a short form. The method was implemented 
with a sample of 7,850 participants from 20 primary PHQ-9 diagnostic studies. The 4-item 
version was developed and validated based on pre-specified constraints on its test information, 
reliability, validity, and diagnostic accuracy.  
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Table 1. Patient demographic and diagnostic characteristics (N = 7850) 
Sociodemographic variables Summary 
Age, years, mean [median] ± SD (range) 52.0 [54] ± 18.1 (18, 102) 
Women, n (%) 4335 (55.2) 
PHQ-9 score, mean [median] ± SD (range) 5.2 [3]  ± 5.4 (0, 27) 
Country, n (%)  
    USA 2781 (35.4) 
    New Zealand 2528 (32.2) 
    Australia 1092 (13.9) 
    Canada 573 (7.3) 
    UK 478 (6.1) 
    Cameroon 398 (5.1) 
Care Setting, n (%)  
    Primary care 2928 (37.3) 
    Non-medical setting 1389 (17.7) 
    Perinatal care 665 (8.5) 
    Neurology 607 (7.7) 
    HIV/AIDS care 398 (5.1) 
    Oncology 273 (3.5) 
    Medical rehabilitation 211 (2.7) 
    Rheumatology 201 (2.6) 
    Cardiology 100 (1.3) 
    Stroke care 72 (0.9) 
    Outpatients with coronary artery disease 1006 (12.8) 
Diagnostic Interview, n (%)  
    CIDI 3949 (50.3) 
    SCID 2443 (31.1) 
    DIS 1006 (12.8) 
    SCAN 352 (4.5) 
    DISH 100 (1.3) 
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Classification system, n (%)  
    DSM-IV 6859 (87.4) 
    ICD-10 822 (10.5) 
    DSM-V 169 (2.2) 
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Table 2. PHQ-9 items and discrimination parameters from the generalized partial credit 
model 
Item 
Number 
Description Discrimination 
Parameter 
1 Little interest or pleasure in doing things 1.95 
2 Feeling down, depressed, or hopeless 2.40 
3 Trouble falling or staying asleep, or sleeping too much 0.93 
4 Feeling tired or having little energy 1.37 
5 Poor appetite or overeating 1.08 
6 Feeling bad about yourself – or that you are a failure or have 
let yourself or your family down 
1.90 
7 Trouble concentrating on things, such as reading newspaper 
or watching television 
1.41 
8 Moving or speaking so slowly that other people could have 
noticed? Or the opposite – being so fidgety or restless that 
you have been moving around a lot more than usual 
1.29 
9 Thoughts that you would be better off dead or of hurting 
yourself in some way 
1.77 
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Table 3. Items included in optimal short forms of each length with item 9 included and item 9 excluded 
Item Number (X indicates inclusion) 
Short 
Form 
Length 
1 
Little 
interest 
2 
Feeling 
down 
3 
Sleep 
problem 
4 
Feeling 
Tired 
5 
Appetite 
6 
Feeling 
failure 
7 
Concentration 
8 
Physical 
Movement 
9 
Thoughts of 
Death or Self-
Harm 
Item 9 Eligible for Inclusion in Short Forms 
1         X 
2  X       X 
3 X X       X 
4 X X    X   X 
5 X X    X  X X 
6 X X    X X X X 
7 X X  X  X X X X 
8 X X  X X X X X X 
Item 9 Ineligible for Inclusion in Short Forms 
1  X        
2 X X        
3 X X    X    
4 X X    X  X  
5 X X    X X X  
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6 X X  X  X X X  
7 X X  X X X X X  
8 X X X X X X X X  
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Table 4. Reliability and validity results of the candidate short forms 
Form 
Length 
Cronbach’s alpha (95% CI) Correlation of summed 
scores (95% CI) 
Correlation of factor 
scores (95% CI) 
Item 9 Eligible for Inclusion in Short Forms   
1 NA 0.527 (0.511, 0.543) NA 
2 0.533 (0.504, 0.563) 0.804 (0.796, 0.811) 0.800 (0.792, 0.808) 
3 0.727 (0.712, 0.741) 0.863 (0.857, 0.868) 0.869 (0.863, 0.874) 
4 0.801 (0.790, 0.810) 0.892 (0.887, 0.896) 0.895 (0.890, 0.899) 
5 0.809 (0.799, 0.819) 0.920 (0.916, 0.923) 0.912 (0.909, 0.916) 
6 0.835 (0.826, 0.843) 0.939 (0.937, 0.942) 0.931 (0.928, 0.934) 
7 0.846 (0.839, 0.854) 0.971 (0.970, 0.973) 0.980 (0.979, 0.980) 
8 0.858 (0.851, 0.865) 0.986 (0.986, 0.987) 0.989 (0.989, 0.990) 
9 0.866 (0.860, 0.873) 1.000 (1.000, 1.000) 1.000 (1.000, 1.000) 
Item 9 Ineligible for Inclusion in Short Forms 
1 NA 0.781 (0.772, 0.79) NA 
2 0.779 (0.763, 0.794) 0.849 (0.842, 0.855) 0.860 (0.855, 0.866) 
3 0.816 (0.806, 0.826) 0.887 (0.882, 0.892) 0.891 (0.886, 0.895) 
4 0.805 (0.795, 0.814) 0.919 (0.916, 0.923) 0.910 (0.907, 0.914) 
5 0.832 (0.824, 0.840) 0.940 (0.936, 0.941) 0.930 (0.927, 0.933) 
6 0.845 (0.838, 0.852) 0.970 (0.969, 0.971) 0.978 (0.977, 0.979) 
7 0.857 (0.850, 0.863) 0.984 (0.984, 0.985) 0.988 (0.987, 0.988) 
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8 0.866 (0.860, 0.872) 0.997 (0.997, 0.997) 0.998 (0.998, 0.998) 
Bold values represent those of the final selected form. 
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Table 5. Diagnostic accuracy results of the candidate short forms and their non-inferiority test results  
Form 
Length 
Optimal 
Cutoff 
Sensitivity (95% CI) P-value  Specificity (95% CI) P-value  
Item 9 Eligible for Inclusion in Short Forms    
1 1 0.420 (0.369, 0.437) 0.976 0.943 (0.930, 0.954) 0.000 
2 1 0.929 (0.900, 0.950) 0.000 0.650 (0.592, 0.685) 0.976 
3 2 0.892 (0.843, 0.927) 0.000 0.717 (0.680, 0.751) 0.976 
4 3 0.858 (0.810, 0.895) 0.000 0.776 (0.744, 0.805) 0.976 
5 4 0.806 (0.749, 0.853) 0.000 0.826 (0.798, 0.851) 0.066 
6 5 0.837 (0.808, 0.863) 0.000 0.837 (0.808, 0.863) 0.000 
7 7 0.814 (0.715, 0.884) 0.000 0.849 (0.820, 0.873) 0.000 
8 7 0.856 (0.855, 0.857) 0.000 0.802 (0.801, 0.804) 0.976 
9 10 0.761 (0.679, 0.787) NA 0.866 (0.836, 0.892) NA 
Item 9 Ineligible for Inclusion in Short Forms   
1 1 0.916 (0.877, 0.944) 0.000 0.650 (0.599, 0.698) 0.976 
2 2 0.880 (0.825, 0.919) 0.000 0.725 (0.688, 0.760) 0.976 
3 3 0.844 (0.796, 0.882) 0.000 0.784 (0.752, 0.813) 0.976 
4 4 0.788 (0.725, 0.840) 0.000 0.837 (0.809, 0.861) 0.000 
5 5 0.792 (0.716, 0.873) 0.000 0.848 (0.820, 0.873) 0.000 
6 6 0.855 (0.762, 0.916) 0.000 0.807 (0.773, 0.838) 0.976 
7 7 0.844 (0.762, 0.902) 0.000 0.810 (0.776, 0.840) 0.976 
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8 8 0.871 (0.786, 0.925) 0.000 0.784 (0.746, 0.819) 0.976 
Bold values represent those of the final selected form. 
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FIGURES 
 
Figure 1. The left hand plot shows the item information functions for each of the 9 items. The right hand plot shows the test 
information function of the PHQ-9.  
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Supplementary Methods 1. Search Strategies 
MEDLINE (OvidSP) 
 
1. PHQ*.af. 
2. patient health questionnaire*.af. 
3. 1 or 2 
4. Mass Screening/ 
5. Psychiatric Status Rating Scales/ 
6. "Predictive Value of Tests"/ 
7. "Reproducibility of Results"/ 
8. exp "Sensitivity and Specificity"/ 
9. Psychometrics/ 
10. Prevalence/ 
11. Reference Values/ 
12.. Reference Standards/ 
13. exp Diagnostic Errors/ 
14. Mental Disorders/di, pc [Diagnosis, Prevention & Control] 
15. Mood Disorders/di, pc [Diagnosis, Prevention & Control] 
16. Depressive Disorder/di, pc [Diagnosis, Prevention & Control] 
17. Depressive Disorder, Major/di, pc [Diagnosis, Prevention & Control] 
18. Depression, Postpartum/di, pc [Diagnosis, Prevention & Control] 
19. Depression/di, pc [Diagnosis, Prevention & Control] 
20. validation studies.pt. 
21. comparative study.pt. 
22. screen*.af. 
23. prevalence.af. 
24. predictive value*.af. 
25. detect*.ti. 
26. sensitiv*.ti. 
27. valid*.ti. 
28. revalid*.ti. 
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29. predict*.ti. 
30. accura*.ti. 
31. psychometric*.ti. 
32. identif*.ti. 
33. specificit*.ab. 
34. cut?off*.ab. 
35. cut* score*.ab. 
36. cut?point*.ab. 
37. threshold score*.ab. 
38. reference standard*.ab. 
39. reference test*.ab. 
40. index test*.ab. 
41. gold standard.ab. 
42. or/4-41 
43. 3 and 42 
47. limit 43 to yr=”2000-Current” 
 
PsycINFO (OvidSP) 
 
1. PHQ*.af. 
2. patient health questionnaire*.af. 
3. 1 or 2 
4. Diagnosis/ 
5. Medical Diagnosis/ 
6. Psychodiagnosis/ 
7. Misdiagnosis/ 
8. Screening/ 
9. Health Screening/ 
10. Screening Tests/ 
11. Prediction/ 
12. Cutting Scores/ 
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13. Psychometrics/ 
14. Test Validity/ 
15. screen*.af. 
16. predictive value*.af. 
17. detect*.ti. 
18. sensitiv*.ti. 
19. valid*.ti. 
20. revalid*.ti. 
21. accura*.ti. 
22. psychometric*.ti. 
23. specificit*.ab. 
24. cut?off*.ab. 
25. cut* score*.ab. 
26. cut?point*.ab. 
27. threshold score*.ab. 
28. reference standard*.ab. 
29. reference test*.ab. 
30. index test*.ab. 
31. gold standard.ab. 
32. or/4-31 
33. 3 and 32 
38. Limit 33 to “2000 to current” 
 
Web of Science (Web of Knowledge) 
 
#1: TS=(PHQ* OR “Patient Health Questionnaire*”) 
#2: TS= (screen* OR prevalence OR “predictive value*” OR detect* OR sensitiv* OR valid* 
OR revalid* OR predict* OR accura* OR psychometric* OR identif* OR specificit* OR cutoff* 
OR “cut off*” OR “cut* score*” OR cutpoint* OR “cut point*” OR “threshold score*” OR 
“reference standard*” OR “reference test*” OR “index test*” OR “gold standard”) 
#1 AND #2 
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Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2014 
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Supplementary Figure 1. Flow diagram of study selection process 
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Supplementary Table 1. Characteristics of included primary studies 
 
First Author, Year Country Recruited Population 
Diagnostic 
Interview 
Classificati
on System 
Total N 
Major 
Depression 
N (%) 
Amoozegar, 
Unpublished 
Canada Migraine patients  SCID DSM-IV 203 49 (24) 
Arroll, 2010 (1) New Zealand Primary care patients CIDI DSM-IV 2528 156 (6) 
Bombardier, 2012 (2) USA Inpatients with spinal cord injuries SCID DSM-IV 160 14 (9) 
Eack, 2006 (3) USA Women seeking psychiatric services for 
their children at two mental health centers 
SCID DSM-IV 48 12 (25) 
Fiest, 2014 (4) Canada Epilepsy outpatients SCID DSM-IV 169 23 (14) 
Gjerdingen, 2009 (5) USA Mothers registering their newborns for 
well-child visits at medical or pediatric 
clinics 
SCID DSM-IV 419 19 (5) 
Kiely, 2014 (6) Australia Community sample of adults CIDI ICD-10 822 33 (4) 
Lambert, 2015 (7)a Australia Cancer patients SCID DSM-IV 147 21 (14) 
McGuire, 2013 (8) USA Acute coronary syndrome inpatients DISH DSM-IV 100 9 (9) 
Pence, 2012 (9) Cameroon HIV-infected patients CIDI DSM-IV 398 11 (3) 
Razykov, 2013 (10) Canada Patients with systemic sclerosis CIDI DSM-IV 201 7 (3) 
Richardson, 2010 (11) USA Older adults undergoing in-home aging 
services care management assessment  
SCID DSM-IV 377 95 (25) 
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Rooney, 2013 (12) UK Adults with cerebral glioma SCID DSM-IV 126 14 (11) 
Sidebottom, 2012 (13) USA Pregnant women SCID DSM-IV 246 12 (5) 
Simning, 2012 (14) USA Older adults living in public housing SCID DSM-IV 190 10 (5) 
Thombs, 2008 (15) USA Outpatients with coronary artery disease C-DIS DSM-IV 1006 221 (22) 
Turner, Unpublished Australia Cardiac rehabilitation patients SCID DSM-IV 51 4 (8) 
Turner, 2012 (16) Australia Stroke patients  SCID DSM-IV 72 13 (18) 
Twist, 2013 (17) UK Type 2 diabetes outpatients SCAN DSM-IV 352 79 (22) 
Williams, 2012 (18) USA Parkinson’s disease patients  SCID DSM-IV 235 61 (26) 
Abbreviations: C-DIS: Computerized Diagnostic Interview Schedule; CIDI: Composite International Diagnostic Interview; DISH: Depression Interview and 
Structured Hamilton; DSM: Diagnostic and Statistical Manual of Mental Disorders; ICD: International Classification of Diseases; PHQ-9: Patient Health 
Questionnaire-9; SCAN: Schedules for Clinical Assessment in Neuropsychiatry; SCID: Structured Clinical Interview for DSM Disorders; UK: United Kingdom; 
USA: United States of America. 
aWas unpublished at the time of electronic database search 
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Supplementary Table 2. The Patient Health Questionnaire-4 Item Short Form (PHQ-DEP-
4) 
Over the last 2 weeks, how often have you been 
bothered by any of the following problems?  
Not at 
all 
Several 
days 
More 
than 
half the 
days 
Nearly 
every 
day 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. Feeling bad about yourself — or that you are a 
failure or have let yourself or your family down 
0 1 2 3 
4. Moving or speaking so slowly that other people 
could have noticed? Or the opposite – being so 
fidgety or restless that you have been moving 
around a lot more than usual. 
0 1 2 3 
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